D44 is a Plasmodium FKBP35 inhibitor that selectively inhibits the PPIase activity of FKBP35, with IC50 values of 132 nM and 125 nM against Plasmodium falciparum and Plasmodium vivax PPIase, respectively; it exhibits antiplasmodial activity and can be used in research related to infectious diseases.